Skip to content

Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

Hospital-based Surveillance to Estimate the Disease Burden of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01253967
Enrollment
1234
Registered
2010-12-06
Start date
2008-02-29
Completion date
2010-01-31
Last updated
2015-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections, Rotavirus

Keywords

Gastroenteritis, Hospital surveillance, Rotavirus gastroenteritis

Brief summary

The purpose of this hospital based study is to estimate the proportion of rotavirus gastroenteritis in children \< 5 years of age in Romania.

Detailed description

The study consist of a main study and a health economics study Main study: The study will focus on three different groups of patients: * Subjects who are hospitalised for acute gastroenteritis. * Subjects who visit an emergency room for acute gastroenteritis. * Subjects who have rotavirus positive laboratory results and developed acute gastroenteritis at least 48 hours after hospitalisation. Health economics study: for a subset of subjects, additional economic data will be gathered by completing a questionnaire

Interventions

Stool samples will be tested for the presence of rotavirus and a subset of rotavirus positive samples will be genotyped.

OTHERHealth economics questionnaire

For a subset of subjects, additional economic data will be gathered by completing a questionnaire

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 5 Years
Healthy volunteers
No

Inclusion criteria

* A male or female child aged \< 5 years at the time of admission. A child becomes ineligible on the day of her/his fifth birthday. * A subject, who during the study period: * Is hospitalised for acute gastroenteritis Or * Visits an emergency room for acute gastroenteritis Or * Has rotavirus positive laboratory results and develops acute gastroenteritis at least 48 hours after hospitalisation

Exclusion criteria

Not applicable

Design outcomes

Primary

MeasureTime frame
Proportion of rotavirus gastroenteritis among all acute gastroenteritis hospitalisations of children < 5 years of ageAt least 12 months from study start
Proportion of rotavirus gastroenteritis among all acute gastroenteritis emergency room visits for children < 5 years of ageAt least 12 months from study start
Incidence of medical care associated rotavirus gastroenteritis among all hospitalised children < 5 years of ageAt least 12 months from study start

Secondary

MeasureTime frame
Rotavirus gastroenteritis associated costsAt least 12 months from study start
Proportion of acute gastroenteritis among all hospitalisations of children < 5 years of ageAt least 12 months from study start
Proportion of community acquired acute gastroenteritis among all emergency room visits for children < 5 years of ageAt least 12 months from study start
Age distribution of children with rotavirus gastroenteritisAt least 12 months from study start
Severity of rotavirus among all children < 5 years of ageAt least 12 months from study
Proportion of rotavirus gastroenteritis among all hospitalisations of children < 5 years of ageAt least 12 months from study start
Proportion of community acquired rotavirus gastroenteritis among all emergency room visits for children < 5 years of ageAt least 12 months from study start
Seasonal distribution (if appropriate) of rotavirus among all children < 5 years of ageAt least 12 months from study start
Percentage of rotavirus genotypes amongst all isolated strains in children < 5 years of ageAt least 12 months from study start
Potential risk factors for rotavirus gastroenteritisAt least 12 months from study start

Countries

Romania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026